In the News
LACRIFILL® Canalicular Gel is changing clinical practice and changing lives when it comes to dry eye treatment. Latest NewsNordic Group B.V. Through its Subsidiary Nordic Pharma, Inc. (U.S.), Announces LACRIFILL® Canalicular Gel Inclusion in New Dry Eye Workshop (DEWS) III Management and Therapy Report From The Tear Film and Ocular Surface Society (TFOS) in American Journal of Ophthalmology
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Presenting Patient Data and Patient Experience Study for LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces Details of LACRIFILL® Canalicular Gel Poster Presentation At SECO 2025
Come meet with us at these 2026 Meetings and Conferences
ASCRS
April 10–13
Washington D.C.
Vision Source Exchange
April 29–May 2
Nashville, TN
AAO
October 10–12
New Orleans, LA